- Home
- INKT vs TRAW Comparison
INKT vs TRAW Comparison
Compare INKT & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- TRAW
- Stock Information
- Founded
- INKT 2017
- TRAW 1998
- Country
- INKT United States
- TRAW United States
- Employees
- INKT N/A
- TRAW N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- TRAW
- Sector
- INKT Health Care
- TRAW
- Exchange
- INKT Nasdaq
- TRAW NYSE
- Market Cap
- INKT 36.7M
- TRAW 9.5M
- IPO Year
- INKT 2021
- TRAW 2013
- Fundamental
- Price
- INKT $8.43
- TRAW $2.79
- Analyst Decision
- INKT Strong Buy
- TRAW
- Analyst Count
- INKT 2
- TRAW 0
- Target Price
- INKT $19.50
- TRAW N/A
- AVG Volume (30 Days)
- INKT 11.3K
- TRAW 132.7K
- Earning Date
- INKT 03-18-2025
- TRAW 03-31-2025
- Dividend Yield
- INKT N/A
- TRAW N/A
- EPS Growth
- INKT N/A
- TRAW N/A
- EPS
- INKT N/A
- TRAW N/A
- Revenue
- INKT N/A
- TRAW $226,000.00
- Revenue This Year
- INKT N/A
- TRAW $3.81
- Revenue Next Year
- INKT N/A
- TRAW N/A
- P/E Ratio
- INKT N/A
- TRAW N/A
- Revenue Growth
- INKT N/A
- TRAW N/A
- 52 Week Low
- INKT $4.56
- TRAW $2.02
- 52 Week High
- INKT $19.00
- TRAW $27.50
- Technical
- Relative Strength Index (RSI)
- INKT 41.71
- TRAW 29.98
- Support Level
- INKT $7.54
- TRAW $2.55
- Resistance Level
- INKT $8.88
- TRAW $2.92
- Average True Range (ATR)
- INKT 0.86
- TRAW 0.46
- MACD
- INKT -0.25
- TRAW 0.01
- Stochastic Oscillator
- INKT 6.05
- TRAW 26.62
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.